The Global Chronic Low Back Pain Market Report is a compilation of comprehensive research studies of various aspects of the Chronic Low Back Pain Market. With accurate data and highly authentic information, a brilliant attempt is made to paint a true, transparent picture of the current and future situations of the global Chronic Low Back Pain market. Market participants can use this powerful tool when creating effective business plans or making major changes to their strategies. The report discusses the growth of the global as well as regional markets. It also throws light on high-growth segments of the global Chronic Low Back Pain market and how they will evolve in the years to come.
Request a PDF sample copy of this report at @ https://www.absolutemarketsinsights.com/request_sample.php?id=313
In terms of revenue, the global chronic low back pain market stood at US$ 6429.30 Mn in 2022 and is anticipated to reach US$ 10012.52 Mn by 2030, expanding at a CAGR of 4.8% over the next eight years.. Astellas Pharma Inc., Grunenthal GmbH, Orion Oyj, Pfizer Inc., Regeneron Pharmaceuticals, Inc, Array BioPharma Inc., Egale Corporation, Gador S.A. Kineta., Inc, MEDRx Co., Ltd amongst others.
Growing share of ageing population across several regions combined with sedentary lifestyle and obesity are the primary causative factors modifying the overall chronic low back pain market. Amongst these, it has been reported that sedentary lifestyle is the primary reason for the global industry growth. Sometimes, when a weekday routine of getting too little exercise is compensated by a strenuous weekend workout, it can develop chronic pain on the lower back.
A recent study highlights that the high cost of diagnosis and treatment of chronic lower back pain is leading to burn in the pockets of patients which is leading to Chronic Low Back Pain Market. According to the American Chiropractic Association report, America spends approximately USD 50,000 million in health care for the low-back pain each year .These findings are alarming, considering the socio-economic impact of chronic low back pain. Health care stakeholders are aiming to solve the current challenges and to build a sustainable foundation for affordable, accessible, high-quality chronic low back pain treatment.
Procedures such as minimally invasive injections is used for managing chronic low back pain conditions. The epidural steroid injections during minimally invasive pain treatment helps in reducing inflammation and pain that is usually accompanied with it. The steroid injected is a good option for patients suffering from degenerative disc disease, spinal stenosis and herniated discs. The minimal-invasive pain treatments also includes facet joint injections, medial branch blocks, trigger point injections , viscoelastic hyaluronate injections, stem cell concentrate (PRP and/or BMAC) injections and radiofrequency ablation of nerves. Other treatment methods duly includes acupuncture, nutritional therapy, dry needling, and magnets usage amongst others. Such factors are expected to propel the global Chronic Low Back Pain Market growth in the future years.
The medication market segment have several providers who have formulations with expiring patents. This proves an opportunity for pharmaceutical companies to venture into the market targeting particular medication types for future growth. The Chronic Low Back Pain Market has barriers to entry which include the required technical expertise for creation of new formulations, and related regulatory infrastructure, limiting companies with newer formulations to venture into the market. Thus, the threat of new entrants is rated as low to moderate.
The types of medications used for treating chronic low back pain are analgesic medications, nonsteroidal anti-inflammatory drugs, counter irritants, antidepressants and anticonvulsants. Acetaminophen remains one of the best first-line treatments of chronic low back pain. Analgesic medications held the largest share in 2018 and is expected to continue the same trend over the forecast period. This particular medication group are specifically designed to relieve pain. Analgesic medications include prescription opioids such as oxycodone, morphine, codeine and hydrocodone as well as OTC acetaminophen and aspirin.
North America accounted the largest penetration in Chronic Low Back Pain Market 2018 owing to the prevalence of inflammatory back pain conditions amongst the United States adults. Pain management programs such as Functional Restoration (FR) were introduced for chronic low back pain patients facing debilitating effects related to an overall pain syndrome. The interdisciplinary approach is basically aimed at customizing the treatment options in order to promote maximum rehabilitation in both psychological and physical areas. This is primarily achieved by using a combination of cognitive behavioral therapy (CBT), psychosocial evaluations and physical conditioning that are in turn carefully monitored by a team of experienced health-care professionals. The same has shown highly effective in terms of therapeutic application. Other forms of physical modalities includes chiropractic care, myofascial-release therapy and exercise.
Purchase the latest in-depth Market Report @ https://www.absolutemarketsinsights.com/checkout?id=313
Chronic Low Back Pain Market:
- By Diagnosis
- Computerized Tomography (CT)
- Bone Scans
- Ultrasound Imaging
- By End User
- Ambulatory Surgical Centers
- By Treatment
- Analgesic Medications
- Non-Steroidal Anti-Inflammatory Drugs
- Counter Irritants
- By Surgery
- Vertebroplasty and Kyphoplasty
- Spinal Laminectomy
- Disectomy or Microdiscectomy
- Intradiscal Electrothermal Theraphy (IDET)
- Spinal Fusion
- Artificial Disc Replacement
- By Region
- North America
- The UK
- Nordic Countries
- Benelux Union
- The Netherlands
- Rest of Europe
- Asia Pacific
- New Zealand
- South Korea
- Southeast Asia
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Latin America
- Rest of Latin America
- North America
Besides target market information, Absolute Markets Insights also provides information about your competitor, your customers, products etc. A few techniques we use are:
- Customer analysis
- Competitor analysis
- Risk analysis
- Product research
- Advertising research
- E-mail survey and many more…
- Market Research Methodology
We define the research problem: The step defining the research problem exists of two main steps:
- Formulating the problem
- Establishing research objectives
- Selecting and Establishing Research Design
The step selecting and establishing research design consists of three main steps:
- Select the research design
- Identify information types and sources
- Determine and design research instrument
Read Detailed Index of full Research Study @ https://www.absolutemarketsinsights.com/reports/Chronic-Low-Back-Pain-Market-2019-2027-313
Browse more trending reports by Absolute Markets Insights:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: firstname.lastname@example.org
Phone: IN +91-7400-24-24-24, US +1-510-420-1213